|
|
New IL-6R Inhibitory Antibodies |
|
FDA-approved Antibodies for Rheumatoid Arthritis |
|
|
|
|
Tocilizumab |
|
Tocilizumab is a humanized monoclonal antibody that binds to the IL-6R, MW: 148 KD. |
The FDA approved tocilizumab to treat moderate to severely active rheumatoid arthritis,systemic juvenile idiopathic arthritis and polyarticular juvenile idiopathic arthritis. |
|
|
|
Sarilumab |
|
Synonyms: SAR153191, REGN88 |
Sarilumab is a fully humanized IL-6R mAb that binds membrane-bound and soluble human IL-6Rα with high affinity, MW: 144.13 KD. |
FDA approval of sarilumab for the treatment of moderate to severely active rheumatoid arthritis in adult patients. |
|
|
|
Adalimumab |
|
Adalimumab is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha, MW: 144.19 KD. |
Adalimumab receives FDA Approval for First-Line Treatment of Moderate to Severe Rheumatoid Arthritis |
|
|
|
|
Our products are not for human consumption |
|
Tel: +1-832-582-8158 Fax: +1-832-582-8590 Email: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. Add: 9330 Kirby drive, STE 200 Houston, TX 77054 USA. |
|
Tel: +49-89-46148500 Fax: +49-89-461485022 Email: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. Add: Karl-Schmid-Str. 14, 81829 Munich, Germany. |
|